EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase IV)Open Access · CC BY-NC 4.0

Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE )

Tetsuya Babazono, Takeshi Osonoi, Hideki Okamoto, Yukiko Onishi, Shinya Nakamoto, Masayuki Kashima, Daiji Kawanami, Eitaro Nakashima, Kei Watabe, Noriko Nunami, Katsuhiko Hagi iD

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.70135 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Tetsuya Babazono und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Hypoglycemic Agents, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sumitomo Pharma Co., Ltd., Dainippon Sumitomo Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim To evaluate the long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes (T2D) and advanced chronic kidney disease (CKD). Materials and Methods This open‐label, single‐arm, multicenter, phase 4 study (TWINKLE) enrolled individuals with T2D and estimated glomerular filtration rate (eGFR) < 45 mL/min/1.73 m 2 , treated with ≤1 oral hypoglycemic agent. Participants received 500 mg of imeglimin twice daily if eGFR was 15 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Renal Insufficiency, ChronicHypoglycemic AgentsBiomarkersHumansMaleFemaleMiddle AgedAgedGlomerular Filtration RateJapanProduct Surveillance, PostmarketingBlood GlucoseGlycated HemoglobinFollow-Up StudiesTreatment OutcomePrognosisDiabetic NephropathiesEast Asian People

Stichwörter der Autor:innen

ImegliminRenal insufficiencyType 2 diabetes

Substanzen

Hypoglycemic AgentsBlood GlucoseGlycated HemoglobinBiomarkers

Autor:innen und Institutionen

  • Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Department of Internal Medicine, Naka Kinen Clinic, Naka, Ibaraki, Japan.
  • Department of Endocrinology and Diabetes, Meitetsu Hospital, Nagoya, Japan.
  • Division of Diabetes and Metabolism, The Institute of Medical Science, Asahi Life Foundation, Tokyo, Japan.
  • Department of Internal Medicine, Nakamoto Naika Clinic, Mito, Ibaraki, Japan.
  • Department of General Internal Medicine, Japanese Red Cross Kumamoto Hospital, Kumamoto, Kumamoto, Japan.

ORCID-Profile: Katsuhiko Hagi

Förderung

  • Sumitomo Pharma Co., Ltd.
  • Dainippon Sumitomo Pharma

Zitieren

APA

Babazono, T., Osonoi, T., Okamoto, H., Onishi, Y., Nakamoto, S., Kashima, M., Kawanami, D., Nakashima, E., Watabe, K., Nunami, N., & Hagi, K. (2025). Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE ). Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70135

Vancouver

Babazono T, Osonoi T, Okamoto H, Onishi Y, Nakamoto S, Kashima M, et al. Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE ). Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70135

BibTeX
@article{Babazono2025,
  author = {Babazono, Tetsuya and Osonoi, Takeshi and Okamoto, Hideki and Onishi, Yukiko and Nakamoto, Shinya and Kashima, Masayuki and Kawanami, Daiji and Nakashima, Eitaro and Watabe, Kei and Nunami, Noriko and Hagi, Katsuhiko},
  title = {Long‐term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52‐week postmarketing clinical study ( TWINKLE )},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.70135}
}
Kostenlos starten →